New York, NY -- (SBWIRE) -- 01/14/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: -- Inovio Pharmaceuticals Inc(NYSEMKT:INO),Banco Santander Brasil SA (ADR)(NYSE:BSBR), CEL-SCI Corporation(NYSEMKT:CVM),Two Harbors Investment Corp(NYSE:TWO)
Inovio Pharmaceuticals Inc(NYSEMKT:INO) reported loss -3.79% and closed at $2.54 with the total traded volume of 5.40M shares. Its market capitalization is $529.28M. The stock has a 52-week high price of 3.03 and its 52-week low was recorded at $0.49
Inovio Pharmaceuticals, Inc. is engaged in the development of a new generation of vaccines, called synthetic vaccines, focused on cancers and infectious diseases.
What INO Charts Are Signaling for Traders? Find Out Here
Banco Santander Brasil SA (ADR)(NYSE:BSBR) gain 1.33% and ended at $5.32.The total traded volume was 5.30M shares and market capitalization arrived at $20.22B. The stock has a 52-week high price of $8.19 and its 52-week low was recorded at $5.15 while during last trade its minimum price was $5.28 and it gained the highest price of $5.37.
Banco Santander Brasil SA (the Bank) is a Brazil-based bank. The Bank operates as a multiple service bank through three business segments: Commercial Bank, Global Wholesale Bank and Asset Management and Insurance.
Is BSBR Buy After The Recent Price Movement? Find Out Here
CEL-SCI Corporation(NYSEMKT:CVM)’s reported the increase of 14.51% to close at $0.790 with the overall traded volume of 5.26M shares. Its market capitalization on last close reached to $38.60 million. Its intraday-low price was $0.69 and its hit its day's highest price at $0.83.
CEL-SCI Corporation (CEL-SCI) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.
Should CVM a Buy or Sell Now? Find Out Here
Two Harbors Investment Corp(NYSE:TWO) gain 1.44% settle at $9.89. Its total traded volume during last trading session was 5.23M shares. The overall market worth of this company is about $3.60B. The 52 week range of the stock remained $8.94 - $14.02, while its day's lowest price was $9.66 and its hit its day's highest price at $9.92.
Two Harbors Investment Corp. (Two Harbors) operates as a real estate investment trust (REIT). The Company is focused on investing in, financing and managing residential mortgage-backed securities (RMBS), residential mortgage loans, residential real properties, and other financial assets.
What TWO Charts Are Signaling for Traders? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)